Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
BJU International
|
October 12, 2020
Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer
Leonie Exterkate, Max Peters, Diederik M Somford, et al.
Transplantation
|
December 26, 2015
Frailty and Transplantation
Leonie Exterkate, Bendix R Slegtenhorst, Matthias Kelm, et al.
European Urology Oncology
|
May 25, 2023
Head-to-Head Comparison of <sup>18</sup>F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer
Leonie Exterkate, Rick Hermsen, Heidi V N Küsters-Vandevelde, et al.
European Urology Oncology
|
September 15, 2019
Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial
Olivier Wegelin, Leonie Exterkate, Marloes van der Leest, et al.
The Prostate
|
July 17, 2023
Immunohistochemical and histopathological validation of <sup>18</sup> F-PSMA-1007 PET/CT for intraprostatic cancerous lesions
Joris G Heetman, Rick Hermsen, Leonie Exterkate, et al.
BJU International
|
August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial
Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
European Urology
|
December 8, 2018
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies
Olivier Wegelin, Leonie Exterkate, Marloes van der Leest, et al.
European Urology Oncology
|
June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
BMJ Open
|
December 3, 2025
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Anouk V M Burger, Charlotte W Duinkerken, Jeroen C Jansen, et al.
The Annals of Otology, Rhinology, and Laryngology
|
January 18, 2026
A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy
Anouk V M Burger, Charlotte W Duinkerken, Eleonoor A R Theunissen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
BJU International
|
October 12, 2020
Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer
Leonie Exterkate, Max Peters, Diederik M Somford, et al.
Transplantation
|
December 26, 2015
Frailty and Transplantation
Leonie Exterkate, Bendix R Slegtenhorst, Matthias Kelm, et al.
European Urology Oncology
|
May 25, 2023
Head-to-Head Comparison of <sup>18</sup>F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer
Leonie Exterkate, Rick Hermsen, Heidi V N Küsters-Vandevelde, et al.
European Urology Oncology
|
September 15, 2019
Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial
Olivier Wegelin, Leonie Exterkate, Marloes van der Leest, et al.
The Prostate
|
July 17, 2023
Immunohistochemical and histopathological validation of <sup>18</sup> F-PSMA-1007 PET/CT for intraprostatic cancerous lesions
Joris G Heetman, Rick Hermsen, Leonie Exterkate, et al.
BJU International
|
August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial
Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
European Urology
|
December 8, 2018
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies
Olivier Wegelin, Leonie Exterkate, Marloes van der Leest, et al.
European Urology Oncology
|
June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
BMJ Open
|
December 3, 2025
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Anouk V M Burger, Charlotte W Duinkerken, Jeroen C Jansen, et al.
The Annals of Otology, Rhinology, and Laryngology
|
January 18, 2026
A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy
Anouk V M Burger, Charlotte W Duinkerken, Eleonoor A R Theunissen, et al.
Page
of 2